The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

Liver diseases can be inherited (such as Wilson disease and alpha 1-antitrypsin deficiency) or acquired (for example hepatitis and liver cancer). Late-stage acute liver failure (ALF) has limited ...

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

Mereo Biopharma Group Plc (MREO) has received a new Buy rating, initiated by LifeSci Capital analyst, Cory Jubinville, PhD.Don't Miss Our ...

Fintel reports that on December 24, 2024, LifeSci Capital initiated coverage of Mereo BioPharma Group plc - Depositary ...

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat Ratings reports. Three ...

WVE-007 is a novel approach for treating obesity and is designed to silence INHBE to achieve healthy, sustainable weight loss through fat ...

Geode Capital Management LLC boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 4.5% during the third quarter, according to the company in its most recent filing with the ...

After hours: December 27 at 6:23:51 PM EST Loading Chart for KRYS ...